Graphene Investments Liquidates Entire $2.95 Million Bath & Body Works Stake Amid Turnaround Challenges

Core Insights - Graphene Investments has completely liquidated its position in Bath & Body Works, selling 114,700 shares for an estimated $2.95 million, indicating a significant loss of confidence in the company's turnaround prospects [2][3][9] Company Overview - Bath & Body Works reported a total revenue of $7.35 billion and a net income of $699 million for the trailing twelve months (TTM) [5] - The company has a dividend yield of 3.74% and its share price was $21.45 as of January 26, 2026 [5] Transaction Details - The sale of 114,700 shares resulted in a decrease in the position's end-of-quarter value by $2.95 million, reflecting both the sale and price changes [3][7] - This transaction accounted for 1.85% of Graphene Investments' 13F reportable assets under management (AUM) [7] - Post-sale, Graphene Investments holds zero shares of Bath & Body Works, which previously represented 1.9% of its AUM [7][8] Market Performance - As of January 26, 2026, Bath & Body Works shares have decreased by 39.5% over the past year, underperforming the S&P 500 by 54.05 percentage points [8] Implications for Investors - The complete exit from Bath & Body Works by Graphene Investments suggests a fundamental change in the investment thesis rather than routine portfolio rebalancing, especially following a 25% drop in stock price after disappointing third-quarter results [9] Company Profile - Bath & Body Works offers a range of products including home fragrance, body care, soaps, and sanitizers, primarily through direct-to-consumer sales in North America, with additional revenue from international franchises and wholesale arrangements [10] - The company targets a broad consumer base in the United States and Canada seeking personal care and home fragrance products [10]